Shares of Kura Oncology Inc. (NASDAQ:KURA) rose 6.7% during mid-day trading on Tuesday . The stock traded as high as $5.76 and last traded at $5.70, with a volume of 57,780 shares. The stock had previously closed at $5.34.

KURA has been the topic of several recent analyst reports. Oppenheimer Holdings Inc. restated an “outperform” rating and set a $16.00 price objective on shares of Kura Oncology in a report on Tuesday, June 21st. Zacks Investment Research downgraded Kura Oncology from a “buy” rating to a “hold” rating in a report on Tuesday, May 17th.

The firm’s 50-day moving average price is $4.53 and its 200 day moving average price is $3.72. The firm’s market cap is $110.21 million.

Kura Oncology (NASDAQ:KURA) last announced its earnings results on Wednesday, August 10th. The company reported ($0.36) EPS for the quarter, missing the consensus estimate of ($0.34) by $0.02. Analysts forecast that Kura Oncology Inc. will post ($1.58) earnings per share for the current fiscal year.

Kura Oncology, Inc is a clinical-stage biopharmaceutical company. The Company is engaged in discovering and developing personalized therapeutics for the treatment of solid tumors and blood cancers. Its segment is engaged in the discovery and development of personalized therapeutics for the treatment of solid tumors and blood cancers.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.